adipose tissue
behavior/neurological
N |
• normal food and water intake and energy expenditure
|
cardiovascular system
N |
• normal mesenteric artery resting internal diameter, vessel length, maximal KCl-evoked tension development during L-max determination, and resting tension at L-max
• normal cardiac output, ejection fraction, fractional shortening, stroke volume, end-systolic and end-diastolic left ventricular volume, and E/A
• normal cardiomyocyte, cardiac tissue and aorta morphology
• normal cardiac output, ejection fraction, fractional shortening, left ventricular mass, and E/A after ANG2 infusion
• normal mesenteric artery KCl- or phenylephrine-induced vasocontraction
• normal sodium nitroprusside-evoked vasodilation in mesenteric arteries after precontraction using phenylephrine
|
• increased left ventricular end-diastolic volume after ANG2 infusion
• greater acetylcholine-evoked vasorelaxation in arteries after precontraction using phenylephrine
|
• after ANG2 infusion
|
• attenuated hypertensive response to ANG2 infusion
|
cellular
N |
• no lysosomal acidification in heart, kidney and aorta
|
growth/size/body
N |
• normal heart, kidney and aorta morphology
• normal body fat and fluid mass
• normal kidney-to-body weight and heart-to-body weight ratios after ANG2 infusion
|
homeostasis/metabolism
N |
• normal plasma electrolyte and blood gas levels
• normal food and water intake and energy expenditure
• normal urine volume and urine aldosterone, Na+ and K+ excretion
• normal plasma renin and aldosterone levels
• normal food and water intake after ANG2 infusion
• normal urine osmolality and AVP, Na+ and K+ excretion after ANG2 infusion
• normal blood urea nitrogen after ANG2 infusion
|
liver/biliary system
mortality/aging
• no ANG2 infusion-induced renal tubular vacuolation
• reduced ANG2 infusion-induced urinary albumin excretion
• reduced ANG2 infusion-induced urinary thiobarbituric acid reactive substances excretion
|
renal/urinary system
• after ANG2 infusion
|
reproductive system